186 related articles for article (PubMed ID: 10489626)
1. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
Boone CW; Kelloff GJ
Cancer Surv; 1998; 32():133-47. PubMed ID: 10489626
[TBL] [Abstract][Full Text] [Related]
2. Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia.
Boone CW; Kelloff GJ
J Cell Biochem Suppl; 1994; 19():10-22. PubMed ID: 7823580
[TBL] [Abstract][Full Text] [Related]
3. Biomarker end-points in cancer chemoprevention trials.
Boone CW; Kelloff GJ
IARC Sci Publ; 1997; (142):273-80. PubMed ID: 9354926
[TBL] [Abstract][Full Text] [Related]
4. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents.
Boone CW; Bacus JW; Bacus JV; Steele VE; Kelloff GJ
J Cell Biochem Suppl; 1997; 28-29():1-20. PubMed ID: 9589346
[TBL] [Abstract][Full Text] [Related]
5. Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy.
Boone CW; Kelloff GJ; Steele VE
Cancer Res; 1992 Apr; 52(7):1651-9. PubMed ID: 1551096
[TBL] [Abstract][Full Text] [Related]
6. Karyometry in the early detection and chemoprevention of intraepithelial lesions.
Ranger-Moore J; Alberts DS; Montironi R; Garcia F; Davis J; Frank D; Brewer M; Mariuzzi GM; Bartels HG; Bartels PH
Eur J Cancer; 2005 Sep; 41(13):1875-88. PubMed ID: 16087328
[TBL] [Abstract][Full Text] [Related]
7. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV.
Guillaud M; Adler-Storthz K; Malpica A; Staerkel G; Matisic J; Van Niekirk D; Cox D; Poulin N; Follen M; Macaulay C
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S16-23. PubMed ID: 16188299
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention trials in the cervix: design, feasibility, and recruitment.
Mitchell MF; Hittelman WN; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Hong WK
J Cell Biochem Suppl; 1995; 23():104-12. PubMed ID: 8747384
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and biological significance of cellular DNA content and nuclear size in carcinoma of the uterine cervix].
Gu Q
Zhonghua Yi Xue Za Zhi; 1990 Dec; 70(12):703-5. PubMed ID: 1963378
[No Abstract] [Full Text] [Related]
10. Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.
Mariuzzi L; Mombello A; Rucco V; Morelli L; Zamò A; Thompson D; Vaught L; Bartels HG; Mariuzzi G; Bartels PH
Adv Clin Path; 2000 Apr; 4(2):87-97. PubMed ID: 11080789
[TBL] [Abstract][Full Text] [Related]
11. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples.
de Capoa A; Musolino A; Della Rosa S; Caiafa P; Mariani L; Del Nonno F; Vocaturo A; Donnorso RP; Niveleau A; Grappelli C
Oncol Rep; 2003; 10(3):545-9. PubMed ID: 12684621
[TBL] [Abstract][Full Text] [Related]
12. Surrogate end-point biomarkers in chemopreventive drug development.
Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
Kelloff GJ; Sigman CC; Johnson KM; Boone CW; Greenwald P; Crowell JA; Hawk ET; Doody LA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):127-37. PubMed ID: 10698472
[TBL] [Abstract][Full Text] [Related]
14. Nuclear texture: can it be used as a surrogate endpoint biomarker?
Palcic B
J Cell Biochem Suppl; 1994; 19():40-6. PubMed ID: 7823604
[TBL] [Abstract][Full Text] [Related]
15. In situ assessment of intraepithelial neoplasia in hamster trachea epithelium using angle-resolved low-coherence interferometry.
Chalut KJ; Kresty LA; Pyhtila JW; Nines R; Baird M; Steele VE; Wax A
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):223-7. PubMed ID: 17301253
[TBL] [Abstract][Full Text] [Related]
16. Chromatin texture by computer-assisted image analysis.
Longatto Filho A; Santinelli A; Montironi R
Pathologica; 2000 Apr; 92(2):94-5. PubMed ID: 10838876
[No Abstract] [Full Text] [Related]
17. Detection of underlying characteristics of nuclear chromatin patterns of thyroid tumor cells using texture and factor analyses.
Murata S; Mochizuki K; Nakazawa T; Kondo T; Nakamura N; Yamashita H; Urata Y; Ashihara T; Katoh R
Cytometry; 2002 Nov; 49(3):91-5. PubMed ID: 12442308
[TBL] [Abstract][Full Text] [Related]
18. Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions.
Weyn B; Jacob W; da Silva VD; Montironi R; Hamilton PW; Thompson D; Bartels HG; Van Daele A; Dillon K; Bartels PH
Cytometry; 2000 Oct; 41(2):133-8. PubMed ID: 11002269
[TBL] [Abstract][Full Text] [Related]
19. [The Ljubljana classification of epithelial hyperplastic laryngeal lesions: a morphometric evaluation of nuclear pleomorphism].
Serio G; Gale N; Pennella A; Dalena AM; Giardina C; Valente T; Lettini T; Ricco R; Resta L
Pathologica; 2002 Dec; 94(6):290-8. PubMed ID: 12540992
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
